BCG VACCINE AJV

This brand name is authorized in Estonia, Finland, France, New Zealand, Poland, United Kingdom

Active ingredients

The drug BCG VACCINE AJV contains one active pharmaceutical ingredient (API):

1 BCG vaccine UNII 2XQ558L16Z - BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known. Read about BCG vaccine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BCG VACCINE Powder and solvent for suspension for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AN01	Tuberculosis, live attenuated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AN Tuberculosis vaccines
Discover more medicines within J07AN01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1042186
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 436176
Country: FR	Base de données publique des médicaments	Identifier(s): 61077869
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 372402
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7734
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100203763